Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

Journal of Investigative Dermatology

Volumn 113, Issue 6, 1999, Pages 1076-1081

  Grossman, Douglas ^a   McNiff, Jennifer M ^a   Li, Fengzhi ^a   Altieri, Dario C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antisense; Bcl 2; GFP; IAP protein; Nevus

Indexed keywords

DNA; GREEN FLUORESCENT PROTEIN; PROTEIN BCL 2; SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTE; MELANOMA; NEVUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; WESTERN BLOTTING;

EID: 0033397882     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00776.x     Document Type: Article

References (35)

1. Adams JM, Cory S: The BcI-2 protein family: arbiters of cell survival. Science 281:1322-1326, 1998
2. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC: Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351:882-883, 1998
3. Alanko T, Rosenberg M, Saksela O: FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes. J Invest Dermatol 113:111-116, 1999
4. Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921, 1997
5. Ambrosini G, Adida C, Sirugo G, Altieri DC: Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273:11177-11182, 1998
6. Bohm M, Moellmann G, Cheng E, Alvarez-Franco M, Wagner S, Sassone-Corsi P, Halaban R: Identification of p90RSK as the probable CREB-Ser133 kinase in human melanocytes. Cell Growth Differ 6:291-302, 1995
7. Cerroni L, Soyer HP, Kerl H: bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi. Am J Dermatopathol 17:7-11, 1995
8. Clark WH: Tumor progression and the nature of cancer. Br J Cancer 64: 631-644, 1991
9. Coffins KA, White WL: Intercellular adhesion molecule 1 (ICAM-1) and bcl-2 are differentially expressed in early evolving malignant melanoma. Am J Dermatopathol 17:429-438, 1995
10. Crucioli V, Stilwell J: The histogenesis of malignant melanoma in relation to preexisting pigmented lesions. J Cutan Pathol 9:396-404, 1982
11. Deveraux QL, Reed JC: IAP family proteins - suppressors of apoptosis. Genes Dev 13:239-252, 1999
12. Fisher DE: Apoptosis in cancer therapy: crossing the threshold. Cell 78:539-542, 1994
13. Fodstad O, Aamdal S, McMenamin M, Neslad JM, Pihl A: A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX. Int J Cancer 41:442-449, 1988
14. Glinsky GV, Glinsky VV, Ivanova AB, Hueser CJ: Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with profound deficiency of apoptosis execution mechanisms. Cancer Lett 115:185-193, 1997
15. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ: Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 161:2833-2840, 1998
16. Grossman D, McNiff JM, Li F, Altieri DC: Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 79:1121-1126, 1999
17. Halaban R, Funasaka Y, Lee P, Rubin J, Ron D, Birnbaum D: Fibroblast growth factors in normal and malignant melanocytes. Ann N Y Acad Sci 638:232-243, 1991
18. Halaban R, Cheng E, Zhang Y, et al: Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Fror Natl Acad Sci USA 94:6210-6215, 1997
19. Irmler M, Thome M, Hahne M, et al: Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195, 1997
20. Jansen B, Schlagbauer-Wadl H, Brown BD, et al: Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat Med 4:232-234, 1998
21. Johnson TM, Dolan OM, Hamilton TA, Lu MC, Swanson NA, Lowe L: Clinical and histologic trends of melanoma. J Am Acad Dermatol 78:539-542, 1998
22. Kawasaki H, Altieri DC, Lu C-D, Toyoda M, Tenjo T, Tanigawa N: Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071-5074, 1998
23. Koh HK: Cutaneous melanoma. N Engl J Med 325:171-182, 1991
24. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17:3247-3259, 1998
25. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Machisio PC, Altieri DC: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584, 1998
26. Li G, Tang L, Zhou X, Tron V, Ho V: Chemotherapy-induced apoptosis in melanoma cells is p53 dependent. Melanoma Res 8:17-28, 1998
27. Lu C-D, Altieri DC, Tanigawa N: Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58:1808-1812, 1998
28. Mooney EE, Peris JMR, O'Neill A, Sweeney EC: Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma. J Clin Pathol 48:242-244, 1995
29. Mooy CM, Luyten GPM, de Jong PTVM, et al: Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma. Am J Pathol 147:1097-1104, 1995
30. Selzer E, Schlagbauer-Wadl H, Okamoto I, Pehamberger H, Potter R, Jansen B: Expression of bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines. Melanoma Res 8:197-203, 1998
31. Stauton MJ, Gaffney EF: Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol 103:300-307, 1995
32. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315-5320, 1998
33. Tang L, Tron VA, Reed JC, et al: Expression of apoptosis regulators in cutaneous malignant melanoma. Clin Cancer Res 4:1865-1871, 1998
34. Thomas WD, Hersey P: TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediated CD4 T cell killing of target cells. J Immunol 161:2195-2200, 1998
35. Urist MM, Karnell LH: The National Cancer Database: report on melanoma. Cancer 74:782-788, 1994